Docoh
Loading...

AVCO Avalon GloboCare

Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.

AVCO stock data

(
)

Press releases

Pro users get this 30m faster

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

16 Aug 21
16 Oct 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 685.3K 685.3K 685.3K 685.3K 685.3K 685.3K
Cash burn (monthly) 335.75K 46.98K 788.3K 923.69K 359.34K 517.9K
Cash used (since last report) 1.19M 166.59K 2.8M 3.28M 1.27M 1.84M
Cash remaining -505.15K 518.72K -2.11M -2.59M -588.82K -1.15M
Runway (months of cash) -1.5 11.0 -2.7 -2.8 -1.6 -2.2

Beta Read what these cash burn values mean

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

1.7% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 26 29 -10.3%
Opened positions 11 1 +1000.0%
Closed positions 14 5 +180.0%
Increased positions 3 10 -70.0%
Reduced positions 12 13 -7.7%
13F shares
Current Prev Q Change
Total value 2.06M 7.77M -73.5%
Total shares 1.42M 3.47M -59.2%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Vanguard 580.01K $570K -9.4%
Geode Capital Management 145.26K $142K -45.9%
Millennium Management 141.54K $139K NEW
BLK Blackrock 109.28K $107K -90.0%
Ergoteles 59.8K $59K NEW
Renaissance Technologies 54.91K $54K -89.2%
HRT Financial 54.58K $53K NEW
NTRS Northern Trust 47.28K $46K -80.5%
Boothbay Fund Management 41.66K $41K NEW
VIRT Virtu Financial 37.56K $37K NEW
Largest transactions
Shares Bought/sold Change
BLK Blackrock 109.28K -988.46K -90.0%
Renaissance Technologies 54.91K -454.3K -89.2%
STT State Street 20.05K -266.1K -93.0%
NTRS Northern Trust 47.28K -195.61K -80.5%
Millennium Management 141.54K +141.54K NEW
Geode Capital Management 145.26K -123.41K -45.9%
Vanguard 580.01K -60.31K -9.4%
Ergoteles 59.8K +59.8K NEW
HRT Financial 54.58K +54.58K NEW
Nuveen Asset Management 0 -54.2K EXIT
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: advisor, agricultural, altered, ancillary, announced, attention, aware, beneficial, broad, broadly, category, CEC, cited, clarify, clarity, Commerce, competent, competitive, compliance, comply, concept, confiscatory, contemplated, Cooperative, Council, Crack, critical, CSO, cultural, dealing, degree, direct, directed, disapprove, diversion, domestic, draft, drug, eCapital, energy, enforce, enforcement, engineering, enjoy, equal, escrow, explain, exploit, expropriation, extraterritorial, failing, fall, falling, forfeit, formatted, found, founder, fully, gene, genetic, genetically, great, harm, highest, Illegal, immunology, impede, imposition, inconsistent, Inline, installment, Interactive, Internet, interpret, interpretation, interpreted, interpreting, iv, janitorial, Jianqiang, join, lack, landscape, Lang, Langlang, language, leadership, Lonlon, lose, manner, mentioned, military, Ministry, modification, MOFCOM, NaN, national, nationalization, NPC, official, OpCo, orientated, outcome, oversight, Page, patent, practice, precedential, preclinical, prohibited, prohibition, protracted, Province, provision, proximity, published, qualified, reform, reintroduced, relevant, replaced, requisite, restructure, retroactive, revoking, Runfeng, Sen, Senlang, SenlangBio, serology, Shijiazhuang, significantly, solid, stipulated, strategy, stringent, theoretically, timeline, transition, transport, unanimously, unclear, understanding, unenforceable, unfavorable, unpredictable, user, version, viability, VIE, voting, worst, Zone
Removed: Amidst, curtail, delayed, home, pending, resolution, stay, stayed, traveling, unnecessary